Clinton J Grubbs Selected Research

Clinton J Grubbs Research Topics

Disease

46	Neoplasms (Cancer) 01/2021 - 05/2002
33	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
16	Carcinogenesis 01/2021 - 05/2002
15	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 09/2004
8	Body Weight (Weight, Body) 09/2017 - 01/2002
4	Carcinoma (Carcinomatosis) 11/2014 - 11/2008
2	Adenoma (Adenomas) 10/2018 - 11/2009
2	Hyperplasia 06/2012 - 05/2005
2	Skin Neoplasms (Skin Cancer) 11/2009 - 02/2009
2	Adenocarcinoma 07/2006 - 05/2005
1	Prediabetic State (Prediabetes) 12/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Hypothyroidism 06/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2018
1	Rhabdomyosarcoma 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2016
1	Intestinal Neoplasms (Intestinal Cancer) 07/2016
1	Neuroblastoma 07/2015
1	Hyperlipidemias (Hyperlipidemia) 06/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013
1	Colonic Neoplasms (Colon Cancer) 05/2012

Drug/Important Bio-Agent (IBA)

24	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2021 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2003
11	CarcinogensIBA 09/2019 - 05/2002
10	hydroxide ionIBA 01/2020 - 03/2005
10	Bexarotene (LGD1069)FDA Link 01/2020 - 02/2005
10	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2018 - 08/2003
8	Estrogen ReceptorsIBA 01/2020 - 09/2007
8	RetinoidsIBA 01/2017 - 07/2002
7	Naproxen (Naprosyn)FDA LinkGeneric 01/2020 - 11/2009
7	Tamoxifen FDA LinkGeneric 01/2020 - 11/2003
7	Gefitinib (Iressa)FDA Link 01/2020 - 04/2008
7	Proteins (Proteins, Gene)FDA Link 11/2013 - 05/2003
6	NitrosaminesIBA 09/2017 - 09/2004
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 07/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 09/2010
4	UAB 30IBA 06/2014 - 08/2003
4	Alitretinoin FDA Link 06/2006 - 05/2002
3	vorozoleIBA 01/2020 - 04/2008
3	Cyclin D1IBA 01/2020 - 05/2003
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2015
3	Lapatinib (GW572016)FDA Link 01/2019 - 08/2011
3	Aromatase InhibitorsIBA 09/2018 - 11/2013
3	LigandsIBA 06/2018 - 02/2009
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2014 - 07/2006
3	ErbB Receptors (EGF Receptor)IBA 05/2013 - 04/2008
3	OligonucleotidesIBA 07/2006 - 05/2004
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2004
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2013
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 02/2009
2	Estrogens (Estrogen)FDA Link 09/2019 - 05/2009
2	Triglycerides (Triacylglycerol)IBA 06/2018 - 03/2013
2	Insulin (Novolin)FDA Link 09/2017 - 03/2015
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2016 - 03/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016 - 07/2015
2	AcidsIBA 10/2015 - 08/2003
2	Eflornithine (Ornidyl)FDA Link 02/2014 - 05/2003
2	Tumor Viral Antigens (Large T Antigen)IBA 06/2012 - 05/2003
2	AzoxymethaneIBA 05/2012 - 11/2009
2	Phosphotransferases (Kinase)IBA 08/2011 - 07/2006
2	Messenger RNA (mRNA)IBA 09/2010 - 05/2009
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2009 - 05/2002
2	Dihydrotachysterol (AT 10)IBA 04/2008 - 05/2002
2	tipifarnib (R115777)IBA 07/2006 - 04/2006
2	FenretinideIBA 02/2004 - 01/2002
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	FructoseIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	SaltsIBA 09/2019
1	Tromethamine (Trometamol)FDA Link 09/2019
1	Bile Acids and Salts (Bile Acids)IBA 07/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	NucleotidesIBA 12/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2018
1	Urea (Carbamide)FDA LinkGeneric 12/2018
1	MK 2206IBA 09/2018
1	Protein Kinase InhibitorsIBA 09/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2017
1	benz(a)anthracene (benzanthracene)IBA 07/2016
1	TriterpenesIBA 07/2016
1	Therapeutic UsesIBA 10/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2015
1	Proton Pump InhibitorsIBA 04/2015
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2015
1	BiguanidesIBA 03/2015
1	AMP-Activated Protein KinasesIBA 03/2015
1	Sulindac (Copal)FDA LinkGeneric 02/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014
1	Cyclin A2IBA 11/2013
1	palbociclibIBA 06/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2012
1	Oncogene Proteins (Oncogene Protein)IBA 06/2012
1	Retinoblastoma ProteinIBA 06/2012
1	MicroRNAs (MicroRNA)IBA 02/2012

Therapy/Procedure

10	Therapeutics 01/2016 - 02/2005
8	Chemoprevention 10/2018 - 07/2002
2	Aftercare (After-Treatment) 09/2018 - 01/2016
1	Secondary Prevention 01/2013